Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers
- PMID: 31909824
- PMCID: PMC7021578
- DOI: 10.1002/cncr.32487
Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers
Abstract
Background: Engaging diverse populations in biomedical research, including biospecimen donation, remains a national challenge. This study examined factors associated with an invitation to participate in biomedical research, intent to participate in biomedical research in the future, and participation in biomedical research and biospecimen donation among a diverse, multilingual, community-based sample across 3 distinct geographic areas.
Methods: Three National Cancer Institute-designated cancer centers engaged in community partnerships to develop and implement population health assessments, reaching a convenience sample of 4343 participants spanning their respective catchment areas. Data harmonization, multiple imputation, and multivariable logistic modeling were used.
Results: African Americans, Hispanic/Latinos, and other racial minority groups were more likely to be offered opportunities to participate in biomedical research compared to whites. Access to care, history of cancer, educational level, survey language, nativity, and rural residence also influenced opportunity, intent, and actual participation in biomedical research.
Conclusions: Traditionally underserved racial and ethnic groups reported heightened opportunity and interest in participating in biomedical research. Well-established community partnerships and long-standing community engagement around biomedical research led to a diverse sample being reached at each site and may in part explain the current study findings. However, this study illustrates an ongoing need to establish trust and diversify biomedical research participation through innovative and tailored approaches. National Cancer Institute-designated cancer centers have the potential to increase opportunities for diverse participation in biomedical research through community partnerships and engagement. Additional work remains to identify and address system-level and individual-level barriers to participation in both clinical trials and biospecimen donation for research.
Keywords: biospecimen donation; clinical trials; community engagement; disparities; diversity in research participation; prevention.
© 2020 American Cancer Society.
Conflict of interest statement
Figures





Comment in
-
An invitation for optimal inclusivity: Investing in communities to advance equity in biomedical research and cancer care.Cancer. 2020 Mar 1;126(5):935-938. doi: 10.1002/cncr.32683. Epub 2020 Jan 7. Cancer. 2020. PMID: 31909821 No abstract available.
Similar articles
-
Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement.Cancer. 2014 Apr 1;120 Suppl 7(0 7):1113-21. doi: 10.1002/cncr.28571. Cancer. 2014. PMID: 24643649 Free PMC article.
-
Creating a "culture of research" in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program.Clin Trials. 2015 Jun;12(3):246-56. doi: 10.1177/1740774515571141. Epub 2015 Feb 17. Clin Trials. 2015. PMID: 25691600 Free PMC article.
-
Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers.Cancer. 2017 Jul 1;123(13):2516-2523. doi: 10.1002/cncr.30562. Epub 2017 Feb 27. Cancer. 2017. PMID: 28241089
-
Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.Cancer. 2014 Apr 1;120 Suppl 7(0 7):1091-6. doi: 10.1002/cncr.28575. Cancer. 2014. PMID: 24643646 Free PMC article. Review.
-
Critical Steps for Engaging Hispanics in Cancer Research: Building Capacity to Enhance Participation in Biospecimen Donation with Hispanic Communities.2019 Dec 13. In: Ramirez AG, Trapido EJ, editors. Advancing the Science of Cancer in Latinos [Internet]. Cham (CH): Springer; 2020. Chapter 20. 2019 Dec 13. In: Ramirez AG, Trapido EJ, editors. Advancing the Science of Cancer in Latinos [Internet]. Cham (CH): Springer; 2020. Chapter 20. PMID: 34460192 Free Books & Documents. Review.
Cited by
-
Reimagining diversity in multiple myeloma clinical trials.Hematol Oncol. 2022 Oct;40(4):689-694. doi: 10.1002/hon.2997. Epub 2022 Apr 13. Hematol Oncol. 2022. PMID: 35391496 Free PMC article. No abstract available.
-
Insights into epileptogenesis from post-traumatic epilepsy.Nat Rev Neurol. 2024 May;20(5):298-312. doi: 10.1038/s41582-024-00954-y. Epub 2024 Apr 3. Nat Rev Neurol. 2024. PMID: 38570704 Free PMC article. Review.
-
Development and evaluation of a novel training program to build study staff skills in equitable and inclusive engagement, recruitment, and retention of clinical research participants.J Clin Transl Sci. 2022 Aug 30;6(1):e123. doi: 10.1017/cts.2022.456. eCollection 2022. J Clin Transl Sci. 2022. PMID: 36259068 Free PMC article.
-
Assessing Biomarkers of Breast Cancer Risk in Underserved Women in a Midwestern County.J Prim Care Community Health. 2021 Jan-Dec;12:21501327211017792. doi: 10.1177/21501327211017792. J Prim Care Community Health. 2021. PMID: 34009069 Free PMC article.
-
State and regional estimates using seven cycles of pooled nationally representative HINTS data.Soc Sci Med. 2022 Mar;297:114724. doi: 10.1016/j.socscimed.2022.114724. Epub 2022 Jan 17. Soc Sci Med. 2022. PMID: 35183948 Free PMC article.
References
-
- Al-Refaie WB, Vickers SM, Zhong W, Parsons H, Rothenberger D, Habermann EB. Cancer trials versus the real world in the United States. Annals of surgery. 2011;254(3):438–42; discussion 42–3. - PubMed
-
- Du W, Gadgeel SM, Simon MS. Predictors of enrollment in lung cancer clinical trials. Cancer. 2006;106(2):420–5. - PubMed
-
- Freedman LS, Simon R, Foulkes MA, Friedman L, Geller NL, Gordon DJ, et al. Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993--the perspective of NIH clinical trialists. Controlled clinical trials. 1995;16(5):277–85; discussion 86–9, 93–309. - PubMed
-
- Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. Jama. 2004;291(22):2720–6. - PubMed